US Patent 8,858,946
United States Patent and Trademark Office
University of Iowa Research Foundation (Iowa City, IA, US) ; The United States of America, as represented by the Secretary of the Department of Veterans Affairs (Washington, DC, US)
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.
Stapleton, Jack T.; Xiang, Jinhua; Klinzman, Donna; and Mclinden, James H. Method for inhibiting HIV-1 replication utilizing anti-GBV-C E2 antibodies. US Patent 8,858,946 filed July 24, 2008 and issued October 14, 2014. https://ir.uiowa.edu/patents/628